Harmony Biosciences Holdings, Inc.HRMYNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-36.4%
5Y CAGR-31.7%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-36.4%/yr
Annual compound
5Y CAGR
-31.7%/yr
Recent deceleration
Percentile
P14
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
6 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.89 | -20.0% |
| 2024 | 2.36 | -23.9% |
| 2023 | 3.10 | -57.7% |
| 2022 | 7.33 | -7.3% |
| 2021 | 7.91 | -37.6% |
| 2020 | 12.66 | -96.9% |
| 2019 | 405.37 | - |
| 2018 | 0.00 | - |